Imagine a world where a cancer diagnosis no longer carries the weight of uncertainty, where treatments are tailored to the unique makeup of each patient, and where technology detects the disease before symptoms even appear. This vision is rapidly becoming reality as oncology undergoes a profound
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the evolving landscape of telehealth. Today, we’re diving into the
Nasopharyngeal carcinoma, a challenging foe of the throat, demands a cutting-edge weapon. Standard radiotherapy often seems like a game of chance, beneficial for some, yet elusive for others. Enter machine learning—a revelation poised to change the rules of engagement, offering patients treatment
Could a routine mammogram hold more information than meets the eye? With the advent of artificial intelligence (AI), the potential to transform mammogram analysis into a tool for accurately predicting breast cancer risk is now a tangible reality. This game-changing development has emerged as a
The convergence of artificial intelligence and robotics promises significant advances in modern medicine, a topic recently underscored by the successful patient enrollment in the CANSCAN clinical trial. Spearheaded by Vexev, a prominent Australian medical device company, and U.S. Renal Care, this
Schizophrenia and severe mental illnesses present daunting challenges for the medical community, often leading to a fragmented understanding of their neurological underpinnings. This dilemma has inspired significant research efforts, one of the most revolutionary being the Living Brain Project
